Publication | Open Access

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Gene AmplificationGastrointestinal OncologyMedicineAdvanced Gastric AdenocarcinomaPathologyCancer TreatmentOpen-label StudyOncologyRadiation Oncology